Clinical Trial Update: Outcome of Use of a Novel Modulator of Oxidative Phosphorylation on Kidney Function in Patients With Progressive Chronic Kidney Disease

View source ↗

Summary

A completed trial evaluated a novel modulator of oxidative phosphorylation for kidney function in progressive chronic kidney disease, including patients with CK…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Oxidative phosphorylation modulator (study drug)

Snippet

Sponsor: Neukidney Inc. | Conditions: Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease (Stages 4 and 5) | Status: COMPLETED